No Data
No Data
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $103.86
$6.8 Bn Glaucoma 68-Market Analysis and Sales Forecasts 2023-2033 Featuring Abbvie, Allergan, Alcon, Pfizer, Merck, Santen, Ocular Therapeutix, PH Pharma, Nicox, DWTI, Thea Pharma, Betaliq, and Tarsier Pharma
Berenberg Bank Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $101.94
Berenberg Bank Reaffirms Their Buy Rating on Alcon (ALC)
Needham's Top Stocks for 2025: AX, CYBR, CART and More
Redburn Atlantic Upgrades Alcon(ALC.US) to Buy Rating, Raises Target Price to $102.3
loading...
loading...